Study finds no benefit in adding third drug to therapy for older patients

Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events in older patients with atrial fibrillation who had a heart attack treated with angioplasty, and triple therapy resulted in more complications, according to a study.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1IqOT6M